GEN Exclusives

More »

GEN News Highlights

More »
Feb 13, 2007

NanoInk Receives Patent Rights from Arrowhead Research

  • Arrowhead Research exclusively licensed intellectual property to NanoInk. The patent application covers techniques related to use of surfactants to support NanoInk’s Dip Pen Nanolithography® (DPN®) technology. DPN involves deposition of nanoscale materials onto a substrate.

    Arrowhead’s technology was developed through its sponsored research at the laboratory of Patrick Collier, Ph.D., at the California Institute of Technology.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?